Back to Directory
About
Azurity Pharmaceuticals, Inc. is a pharmaceutical company that specializes in the development and marketing of innovative treatments for various medical conditions. The company is responsible for the manufacturing and distribution of Gliadel Wafer, a carmustine implant used in the treatment of patients with newly-diagnosed high-grade glioma and recurrent glioblastoma. Gliadel Wafer is an adjunct to surgery and radiation therapy, and is designed to provide sustained release of the active ingredient carmustine to the brain tumor site. The company is committed to providing patients with effective treatment options and improving their quality of life. With Gliadel Wafer, Azurity Pharmaceuticals, Inc. is dedicated to helping patients with brain tumors receive the best possible care and treatment.
Quick Facts
- Company Size
- 1-10
- Category
- Medical Organizations
